How AI and Machine Learning are Transforming the Way Discoveries are Made - PULSE

James Collins, Ph.D. is on a mission to end antibiotic resistance with the help of artificial intelligence and machine learning. James Collins, the Termeer Professor of Bioengineering in the Department of Biological Engineering and Institute for Medical Engineering & Science at the Massachusetts Institute of Technology (MIT), has founded several companies based on research in synthetic biology. According to Collins, "the generic principles that apply to physical systems don't extend so well to living organic systems." Collins explains that synthetic biology starts by looking at living systems from an engineering perspective. Rather than simply understanding how everything works, synthetic biologists must determine whether it's possible to reverse-engineer cells to create desirable outcomes.